UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Hollencrest Capital Management

Hollencrest Capital Management raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% in the third quarter, Holdings Channel.com reports. The fund owned 2,278 shares of the healthcare conglomerate’s stock after acquiring an additional 52 shares during the period. Hollencrest Capital Management’s holdings in UnitedHealth Group were worth $890,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of UNH. OLD Mission Capital LLC purchased a new stake in UnitedHealth Group during the third quarter valued at about $439,000. Camden National Bank lifted its stake in UnitedHealth Group by 5.5% during the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $667,000 after buying an additional 100 shares in the last quarter. Hoylecohen LLC lifted its stake in UnitedHealth Group by 9.0% during the first quarter. Hoylecohen LLC now owns 1,149 shares of the healthcare conglomerate’s stock valued at $428,000 after buying an additional 95 shares in the last quarter. Cubist Systematic Strategies LLC increased its holdings in UnitedHealth Group by 216.8% in the first quarter. Cubist Systematic Strategies LLC now owns 8,130 shares of the healthcare conglomerate’s stock worth $3,025,000 after buying an additional 5,564 shares during the last quarter. Finally, Axiom Investment Management LLC acquired a new position in UnitedHealth Group during the first quarter valued at approximately $242,000. 86.20% of the stock is owned by institutional investors.

Several brokerages have commented on UNH. Evercore ISI increased their price target on UnitedHealth Group from $360.00 to $480.00 and gave the company an “outperform” rating in a report on Friday, October 15th. BMO Capital Markets boosted their price objective on shares of UnitedHealth Group from $435.00 to $475.00 and gave the stock a “market perform” rating in a report on Monday, October 18th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $488.00 to $499.00 and gave the stock an “overweight” rating in a report on Friday, October 15th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $421.00 to $477.00 and gave the stock a “buy” rating in a report on Tuesday, November 16th. Finally, Cowen assumed coverage on shares of UnitedHealth Group in a report on Thursday, September 9th. They set an “outperform” rating and a $478.00 price objective on the stock. One investment analyst has rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $477.35.

Shares of UnitedHealth Group stock opened at $450.16 on Thursday. UnitedHealth Group Incorporated has a 1-year low of $320.35 and a 1-year high of $466.00. The firm’s 50-day moving average price is $430.47 and its two-hundred day moving average price is $418.01. The stock has a market capitalization of $423.98 billion, a price-to-earnings ratio of 27.93, a P/E/G ratio of 1.75 and a beta of 0.85. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The company had revenue of $72.34 billion for the quarter, compared to analyst estimates of $71.24 billion. During the same period in the prior year, the business earned $3.51 earnings per share. UnitedHealth Group’s quarterly revenue was up 11.1% on a year-over-year basis. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 18.84 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th will be given a dividend of $1.45 per share. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.29%. UnitedHealth Group’s payout ratio is 35.98%.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction that occurred on Monday, October 25th. The shares were sold at an average price of $448.72, for a total value of $33,654,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction that occurred on Tuesday, September 14th. The shares were sold at an average price of $416.75, for a total transaction of $1,041,875.00. Following the completion of the sale, the director now directly owns 154,403 shares of the company’s stock, valued at approximately $64,347,450.25. The disclosure for this sale can be found here. Insiders have sold 82,500 shares of company stock worth $36,855,125 over the last quarter. 0.55% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Recommended Story: What is the return on assets (ROA) ratio?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.